Klick Health Wraps First Round of $1,000,000 Klick AI Prize, Awarding First $200,000 to Three Teams
May 07 2024 - 1:33PM
Business Wire
Winning entries selected by judging panel of
executives from Boehringer Ingelheim, Bristol Myers Squibb, Lily,
Novartis, Otsuka, Pfizer, Sanofi, and other leading life sciences
companies
Klick Health Co-Founder and Chairman Leerom Segal today
confirmed that after receiving over 200 submissions from team
members across the company, a judging panel of life science company
executives has selected three winning entries for the first round
of the $1,000,000 Klick Prize. Today’s news follows Segal’s
surprise announcement in December that Klick will give away
$1,000,000 in 2024 to its people for game-changing AI ideas that
can fuel the success of healthcare clients.
“We were blown away by both the incredible volume and caliber of
submissions in our first wave of the Klick Prize and can’t thank
our people enough for challenging their thinking and rising to the
occasion,” Segal said. “We are already investing in evolving the
best ideas into prototypes and, based on the judging sessions, we
are confident they will provide tremendous value to our
clients.”
Two members of the agency’s Medical team, a tech developer, and
a project manager are splitting $100,000 in prize money for their
innovative, pharma marketing compliance tool concept, based on an
advanced four-tiered AI approach that could save an average of 10
business days per marketing cycle.
Two other submissions tied for second place, each receiving
$50,000. One of these entries, a unique, personalized AI training
idea for pharma sales reps, was developed by some Client Success
team members. The other, developed by some Strategy team members,
revolves around creating synthetic personas and digital twins to
automate routine tasks and empower healthcare professionals to
focus on more strategic and creative work.
Raising the bar with brilliant, pragmatic AI ideas for life
sciences
Client judges from across the life sciences industry reviewed
and evaluated the submissions based on criteria, including impact,
pragmatism, market differentiation, and desirability. The judges
included C-Suite executives from BeiGene, Boehringer Ingelheim,
Bristol Myers Squibb, Haleon, Lily, New Amsterdam, Novartis,
Novocure, Otsuka, Pfizer, Sanofi, and Sobi.
“We are incredibly grateful to our accomplished panel of
industry judges for helping elevate standards with their critical
thinking and commitment to continuing to raise the health
innovation bar,” Segal said.
Round two of the Klick Prize is now open and the judges will
reconvene this summer. Klick will award another $200,000 in both
rounds two and three, with all first-place winners becoming
contenders for the $400,000 grand finale later in the year.
Today’s news is the latest in the company’s ongoing AI and
machine-learning innovations created to help Klick clients and team
members achieve even greater success.. Earlier this spring, the
agency launched Klick Site AiQ™, an AI-driven marketing
audit and assessment tool, and KCM+AI™, the first AI social
media comment moderator for the life sciences industry. At the
prestigious NeurIPS conference in December, it unveiled
LOVENetTM, an AI framework that rapidly identifies
new uses for existing drugs. In November, it introduced Genome
Perspective, the first AI tool to be developed by an
advertising agency to expedite project planning and increase the
efficiency and velocity of delivery to clients. In October, Klick
Labs announced groundbreaking research, published in Mayo
Clinic Proceedings: Digital Health, around the AI model it created
to detect Type 2 diabetes using 10 seconds of voice; and, in
September, the company launched KlickRx, the first ChatGPT
plugin for the life sciences industry in the U.S.
About Klick Health
Klick Health is the world’s largest independent
commercialization partner for life sciences, focused on hacking the
boundaries of health by developing, launching, and supporting life
sciences brands to achieve their full potential. The agency
provides best-in-class marketing and advertising, media strategy
and purchasing, medical affairs and medical communications, value
and market access services, as well as enterprise omnichannel
enablement among its specialized offerings. Klick’s client service
is rooted in deep medical and scientific understanding, enabled by
over 185 post-graduate, in-house medical experts; unrivaled
decision sciences capabilities; and innovative, results-driven
creative that has made it one of the most-awarded advertising
agencies on the planet.
In 2023, Klick won 160 top creative honors and seven agency
distinctions from the most respected advertising awards shows,
including Clio Health Independent Agency of the Year, London
International Awards’ Global and North American Independent Health
Agency of the Year; and Cannes Lions’ #2 Healthcare Agency, #2
Healthcare Network, and #10 Independent Agency of the Year. Klick
is also consistently ranked a Best Managed Company, Great Place to
Work, Best Workplace for Women, Best Workplace for Inclusion, Best
Workplace for Professional Services, Most Admired Corporate
Culture, and a FORTUNE Best Workplace in Advertising.
Established in 1997, Klick Health (including Klick Katalyst and
btwelve) has offices in New York, Philadelphia, Toronto, London,
São Paulo, and Singapore. It is part of the Klick Group of
companies, which also includes Klick Media Group, Klick Applied
Sciences (including Klick Labs), Klick Consulting, Klick Ventures,
and Sensei Labs. Follow Klick Health on LinkedIn and for
more information on joining Klick, go to
careers.klick.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507872513/en/
Marisa McWilliams PR@klick.com